The Joseph Henry Press, an imprint of the National Academy Press, was created with the goal of making books on science, technology, and health more widely available to profes- sionals and the public.

The global biotechnology market was valued at more than $1.5 trillion in 2023. By 2030, that value is expected to balloon to nearly $4 trillion, according to Grand View Research. To help explain that ...

Andy Lin talks about his role at the major biotech company and his role as a mentor on the Industrial Advisory Board (IAB) for Northwestern Engineering's Master of Biotechnology Program (MBP). Andy ...

The ability of scientists to rationally engineer organisms using synthetic biology, or “engineering biology” as I prefer to call it, has progressed greatly since high throughput molecular biology ...

Yarrowia lipolytica has emerged as a versatile yeast platform for biotechnological applications ranging from biofuel synthesis to high-value chemical production. Its oleaginous nature and robust ...

Karen Lucatero presents the Colombian Case Study at UNIDO Headquarters in Vienna in December 2019. Karen Lucatero's passion for helping people has taken her from a biotechnology engineering background ...

Cutting-edge cellular engineering firm, MaxCyte, has developed a platform, which enables modifications to cells. Applications of MaxCyte's cellular engineering platform are far-reaching, such as ...

Unfortunately, this book can't be printed from the OpenBook. If you need to print pages from this book, we recommend downloading it as a PDF. Visit NAP.edu/10766 to get more information about this ...

- Company also Establishes New Site Leadership Team at Cambridge Facility - GAITHERSBURG, Md., Dec. 20 -- Continuing the solidification of its role as the global biologics unit for AstraZeneca plc (AZ ...

Consortium's technology for synthetic protein engineering offers access to one of the next hot fields in biotechnology WASHINGTON -- Proteins! That's what his elders would tell Dustin Hoffman to ...

General Motors is reducing production at its flagship Factory Zero amid weaker electric vehicle demand, while ImmunityBio has secured approvals to restart its Dunkirk facility for manufacturing its ...